FDA recalls two thyroid medications

News

A picture taken on March 14, 2016 shows tablets and capsules in Paris displayed on a desktop for an illustration in Paris. / AFP / FRANCK FIFE (Photo credit should read FRANCK FIFE/AFP/Getty Images)

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

The Food and Drug Administration has issued a voluntary recall for two thyroid medications made by a Chinese manufacturer because of potential problems with an ingredient.

In the Aug. 9 statement, the FDA said Levothyroxine and Liothyronine 15 mg, 30 mg, 60 mg, 90 mg, and 120 mg thyroid tablets are being recalled as a precaution.

The FDA said the recalled medications were “manufactured using active pharmaceutical ingredients that were sourced prior to the FDA’s import alert.”

“Because these products may be used in the treatment of serious medical conditions, patients taking the recalled medicines should continue taking their medicine until they have a replacement product,” the FDA said.

For a full list of impacted products, visit FDA.gov.

Popular

Latest News

More News